Literature DB >> 32487283

Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020.

Sukhyun Ryu, Seikh Taslim Ali, Cheolsun Jang, Baekjin Kim, Benjamin J Cowling.   

Abstract

We analyzed transmission of coronavirus disease outside of the Daegu-Gyeongsangbuk provincial region in South Korea. We estimated that nonpharmaceutical measures reduced transmissibility by a maximum of 34% without resorting to a strict lockdown strategy. To optimize epidemic control, continuous efforts to monitor the transmissibility are needed.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; SARS-CoV-2; South Korea; coronavirus disease; public health measures; respiratory infections; severe acute respiratory syndrome coronavirus 2; transmissibility; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32487283      PMCID: PMC7510738          DOI: 10.3201/eid2610.201886

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in South Korea on January 20, 2020 (). By April 21, 2020, a total of 10,683 cases of coronavirus disease (COVID-19) in South Korea had been confirmed and 237 persons had died. () (Figure 1, panel A). A large number of COVID-19 cases and deaths resulted from superspreading events in the Daegu-Gyeongsangbuk provincial region of South Korea (Figure 1, panel B). On February 23, 2020, during the early phase of the outbreak as the number of COVID-19 cases increased, public health authorities in South Korea raised the infectious disease alert to its highest level (). Subsequently, enhanced screening and testing in the community (operation of drive-through screening centers and designation of private hospitals where COVID-19 screening testing was available) were implemented (,).
Figure 1

Timeline (A) and geographic distribution (B) of laboratory-confirmed cases of coronavirus disease in South Korea as of April 21, 2020. *Daegu-Gyeongsanbuk provincial region.

Timeline (A) and geographic distribution (B) of laboratory-confirmed cases of coronavirus disease in South Korea as of April 21, 2020. *Daegu-Gyeongsanbuk provincial region. On April 19, 2020, public health authorities in South Korea started to relax social distancing measures, which had been implemented on March 21, 2020; as of April 21, 2020, the COVID-19 epidemic in South Korea had been contained. Recent studies have examined how public health interventions can contain COVID-19 outbreaks (,). However, in the absence of information on public health measures against transmission of SARS-CoV-2 in South Korea, we estimated the transmissibility of SARS-CoV-2 and evaluated the effects of the public health measures implemented outside the Daegu-Gyeongsangbuk provincial region in South Korea.

The Study

We collected data published by local public health authorities in South Korea, including the city or provincial departments of public health. The data comprised date of exposure; date of illness onset; and the source of infection, including contact history and demographic characteristics (e.g., patient birth year and sex). We extracted these line list data of cases by using an electronic data-extraction form. We divided the study into 2 periods, before and after the declaration of highest public alert: period 1 (January 20–February 23, 2020) and period 2 (February 24–April 21, 2020). We restricted our analysis to all other regions in South Korea that excluded Daegu-Gyeongsangbuk provincial region, where there were superspreading events and the data have not been made publicly available (). Over the entire 3-month study period (January 20–April 21, 2020), data were collected for 2,023 cases, which accounted for 98% of the 2,066 reported cases from the South Korea Ministry of Health and Welfare. The median case-patient age was 42 (range 1–102) years, and 820 (41%) case-patients were male (Table). We analyzed the statistical differences in patient age and sex between periods 1 and 2 by using the χ2 test but did not identify any significant differences. The proportion of cases imported from Daegu-Gyeongsangbuk provincial regions was 31% in period 1 and decreased to 5% in period 2. However, during the same periods, the proportion of cases imported from abroad and cases occurring in large clusters increased from 8% to 30%.
Table

Demographic characteristics of 2,023 persons with confirmed cases of coronavirus disease, from publicly available data, South Korea, outside of Daegu-Gyeongsangbuk provincial region on April 21, 2020*

Characteristic All, no. (%) Period 1, no. (%)† Period 2, no. (%)‡
Age group, y



0–19
123 (6)
11 (5)
112 (6)
20–39
715 (35)
104 (50)
611 (34)
40–59
619 (31)
50 (24)
569 (31)
60–79
295 (15)
37 (18)
258 (14)
>80y
50 (3)
6 (3)
44 (2)
Unknown
221 (11)
0
221(12)
Sex



M
820 (41)
107 (56)
713 (39)
F
953 (47)
100 (43)
853 (47)
Unknown
250 (12)
1 (1)
249 (14)
Type of transmission§



Local
892 (44)
116 (55)
776 (43)
Imported from Daegu-Gyeongsangbuk
155 (8)
65 (31)
90 (5)
Imported from abroad
552 (27)
16 (8)
536 (30)
Cases occurring in large clusters424 (21)11 (5)413 (23)

*Assignment to period was based on date of symptom onset. If cases were asymptomatic or date of symptom onset date was not reported, we used the date of case confirmation. 
†Jan 20–Feb 23, 2020; n = 208.
‡Feb 24–Apr 21, 2020; n = 1,815.
§Source of infection is provided for all cases; if not identified, we considered the case to have occurred by local transmission.

*Assignment to period was based on date of symptom onset. If cases were asymptomatic or date of symptom onset date was not reported, we used the date of case confirmation. 
†Jan 20–Feb 23, 2020; n = 208.
‡Feb 24–Apr 21, 2020; n = 1,815.
§Source of infection is provided for all cases; if not identified, we considered the case to have occurred by local transmission. We analyzed the time interval between illness onset and laboratory confirmation for 818 symptomatic case-patients. We estimated the mean time interval from symptom onset to confirmation of COVID-19 during periods 1 and 2 by fitting 3 parametric distributions (Weibull, gamma, and log-normal) and based our selection of best fit on the Akaike information criterion (). We found the log-normal distribution to be the best fit for this time interval, with a mean of 4.6 (95% CI 0.0–12.4) for period 1 and a substantial reduction to 3.4 (0.0–9.0) for period 2. To estimate the incubation period, we analyzed data from 181 case-patients for whom precise contact history with other confirmed case-patients was known. The incubation period was estimated by fitting 3 parametric distributions and best fitted by the log-normal distribution; the overall estimated median incubation period was 4.7 (95% CI 0.1–15.6) days (Appendix). We identified 44 clusters of infection and 79 case-patients who had had clear exposure to only 1 index case-patient among these clusters (Appendix). Overall, serial intervals were negative for 8 of the 79 transmission pairs. We estimated the serial interval distribution by fitting a normal distribution to all 79 observations (). We estimated a mean (± SD) serial interval to be 3.9 (± 4.2) days (Appendix). In mid-February 2020, the number of cases rapidly increased; the largest proportion of cases was among persons who had been infected in Daegu-Gyeongsangbuk provincial region and traveled to other regions of South Korea (Figure 2, panel A). To investigate the effectiveness of nonpharmaceutical interventions implemented in South Korea (Appendix), we estimated the instantaneous effective reproduction number (R), a real-time measure of transmission intensity, from daily onset of cases and our estimated serial interval distribution by using the EpiEstim package in R (,). R is defined as the mean number of secondary infections per primary case with illness onset at time t; R<1 indicates that the epidemic is under control.
Figure 2

Incidence and estimated daily effective reproductive number (R ) of coronavirus disease in regions outside of Daegu-Gyeongsanbuk provincial region, South Korea, as of April 21, 2020. A) The epidemic curve shows the daily number of patients with confirmed cases and symptom onset. For case-patients who did not report any symptoms on the date of case confirmation (n = 1,205 cases; 60% of total), the date of confirmation was plotted instead. B) Daily estimated R and 95% CrI of R; shading indicates the area below the epidemic threshold of R = 1. The vertical dashed line indicates the start of the highest public alert on February 23, 2020. CrI, credible interval.

Incidence and estimated daily effective reproductive number (R ) of coronavirus disease in regions outside of Daegu-Gyeongsanbuk provincial region, South Korea, as of April 21, 2020. A) The epidemic curve shows the daily number of patients with confirmed cases and symptom onset. For case-patients who did not report any symptoms on the date of case confirmation (n = 1,205 cases; 60% of total), the date of confirmation was plotted instead. B) Daily estimated R and 95% CrI of R; shading indicates the area below the epidemic threshold of R = 1. The vertical dashed line indicates the start of the highest public alert on February 23, 2020. CrI, credible interval. We present the daily estimates of R from February 16, 2020, because the stable estimate of R was not available due to the low number of confirmed cases (Figure 2, panel B). At the end of period 1, on February 21, mean R peaked at 2.85 (95% credible interval [CrI] 2.02–3.87) and then started to decline faster to <1 by February 29. R further declined and remained at <1 during the rest of period 2, indicating the potential effect of nonpharmaceutical interventions implemented over time (Figure 2, panel B). Specifically, mean R was 2.23 (CrI 2.05–2.40) before the 1-week period when the declared public alert was at the highest level and reduced to 1.48 (CrI 1.36–1.60) in the following 1-week period, corresponding to a 33.6% (95% CI 23.46%–43.44%) reduction in transmissibility. Similarly, along with the high public alert, the implementation of strict social distancing measures on March 12, 2020, was associated with an R reduction of an additional 9.28% (95% CI 6.80%–11.75%).

Conclusions

Combined nonpharmaceutical interventions, including enhanced screening and quarantining of persons with suspected and confirmed cases and social distancing measures, were implemented over time. Our results suggest that those interventions, without a lockdown, reduced the transmissibility of SARS-CoV-2 in regions outside of the Daegu-Gyeongsangbuk provincial region, in South Korea. Our study has some limitations. First, in our analysis of the changes of transmissibility of SARS-CoV-2, we did not include the large clustered cases reported as superspreading events because in these large clusters, the reporting date may not be a good proxy for the date of infection and would overestimate R(). Second, it is uncertain how many cases were still undetected. This proportion may potentially mislead the actual time trends of number of infections in the population. Third, we based our estimation of time delay on self-reported data, which are not free from reporting (recall) bias. Fourth, government-generated data, including dates of symptom onset, were not available; therefore, we retrieved online case reports, which could have resulted in some inaccuracies in the information used in our analyses. However, the daily numbers of confirmed cases from the collected line list we used was similar to the numbers in the official daily reports (Appendix). Our findings suggest that the nonpharmaceutical interventions implemented in South Korea during the COVID-19 outbreak effectively reduced virus transmissibility and suppressed local spread. However, the population of South Korea is still susceptible to further outbreaks or epidemic waves. Because social distancing measures will be relaxed while opportunities for importation of infections from abroad continue, ongoing monitoring of the effective reproductive number can provide relevant information to help policymakers control a potential second wave of COVID-19.

Appendix

Additional data from study of effect of nonpharmaceutical interventions on transmission of severe acute respiratory syndrome coronavirus 2, South Korea, 2020.
  10 in total

1.  KCDC Risk Assessments on the Initial Phase of the COVID-19 Outbreak in Korea.

Authors:  Inho Kim; Jia Lee; Jihee Lee; Eensuk Shin; Chaeshin Chu; Seon Kui Lee
Journal:  Osong Public Health Res Perspect       Date:  2020-04

2.  Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea.

Authors: 
Journal:  Osong Public Health Res Perspect       Date:  2020-04

3.  Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.

Authors:  Benjamin J Cowling; Sheikh Taslim Ali; Tiffany W Y Ng; Tim K Tsang; Julian C M Li; Min Whui Fong; Qiuyan Liao; Mike Yw Kwan; So Lun Lee; Susan S Chiu; Joseph T Wu; Peng Wu; Gabriel M Leung
Journal:  Lancet Public Health       Date:  2020-04-17

4.  First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment.

Authors:  Kathy Leung; Joseph T Wu; Di Liu; Gabriel M Leung
Journal:  Lancet       Date:  2020-04-08       Impact factor: 79.321

Review 5.  An interim review of the epidemiological characteristics of 2019 novel coronavirus.

Authors:  Sukhyun Ryu; Byung Chul Chun
Journal:  Epidemiol Health       Date:  2020-02-06

6.  A new framework and software to estimate time-varying reproduction numbers during epidemics.

Authors:  Anne Cori; Neil M Ferguson; Christophe Fraser; Simon Cauchemez
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

7.  Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.

Authors:  Juanjuan Zhang; Maria Litvinova; Wei Wang; Yan Wang; Xiaowei Deng; Xinghui Chen; Mei Li; Wen Zheng; Lan Yi; Xinhua Chen; Qianhui Wu; Yuxia Liang; Xiling Wang; Juan Yang; Kaiyuan Sun; Ira M Longini; M Elizabeth Halloran; Peng Wu; Benjamin J Cowling; Stefano Merler; Cecile Viboud; Alessandro Vespignani; Marco Ajelli; Hongjie Yu
Journal:  Lancet Infect Dis       Date:  2020-04-02       Impact factor: 25.071

8.  Improved inference of time-varying reproduction numbers during infectious disease outbreaks.

Authors:  R N Thompson; J E Stockwin; R D van Gaalen; J A Polonsky; Z N Kamvar; P A Demarsh; E Dahlqwist; S Li; E Miguel; T Jombart; J Lessler; S Cauchemez; A Cori
Journal:  Epidemics       Date:  2019-08-26       Impact factor: 4.396

9.  Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.

Authors:  Zhanwei Du; Xiaoke Xu; Ye Wu; Lin Wang; Benjamin J Cowling; Lauren Ancel Meyers
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

10.  Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak.

Authors:  Ki Tae Kwon; Jae Hoon Ko; Heejun Shin; Minki Sung; Jin Yong Kim
Journal:  J Korean Med Sci       Date:  2020-03-23       Impact factor: 2.153

  10 in total
  24 in total

Review 1.  Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020-2021.

Authors:  Chiara Achangwa; Huikyung Park; Sukhyun Ryu; Moo-Sik Lee
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

2.  Social distancing and mask-wearing could avoid recurrent stay-at-home restrictions during COVID-19 respiratory pandemic in New York City.

Authors:  Hae-Young Kim; Anna Bershteyn; Jessica B McGillen; Jaimie Shaff; Julia Sisti; Charles Ko; Radhika Wikramanayake; Remle Newton-Dame; R Scott Braithwaite
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

3.  Identifying COVID-19 Cases and Social Groups at High Risk of Transmission: A Strategy to Reduce Community Spread.

Authors:  Robert A Gunn; John Bellettiere; Richard S Garfein; Kanya C Long; Nancy J Binkin; Cheryl A M Anderson
Journal:  Public Health Rep       Date:  2021-01-28       Impact factor: 2.792

4.  Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.

Authors:  Sukhyun Ryu; Sheikh Taslim Ali; Eunbi Noh; Dasom Kim; Eric H Y Lau; Benjamin J Cowling
Journal:  BMC Infect Dis       Date:  2021-05-26       Impact factor: 3.090

5.  A qualitative study exploring the relationship between mothers' vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months.

Authors:  Kimberly K Walker; Katharine J Head; Heather Owens; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2021-06-30       Impact factor: 4.526

6.  Spatial variability in reproduction number and doubling time across two waves of the COVID-19 pandemic in South Korea, February to July, 2020.

Authors:  Eunha Shim; Amna Tariq; Gerardo Chowell
Journal:  Int J Infect Dis       Date:  2020-10-08       Impact factor: 3.623

7.  The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.

Authors:  You Li; Harry Campbell; Durga Kulkarni; Alice Harpur; Madhurima Nundy; Xin Wang; Harish Nair
Journal:  Lancet Infect Dis       Date:  2020-10-22       Impact factor: 25.071

8.  The Effects of Border Shutdowns on the Spread of COVID-19.

Authors:  Nahae Kang; Beomsoo Kim
Journal:  J Prev Med Public Health       Date:  2020-08-30

9.  Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.

Authors:  Min Joo Choi; Minsun Kang; So Youn Shin; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim; Jaehun Jung; Joon Young Song
Journal:  Int J Infect Dis       Date:  2020-10-27       Impact factor: 3.623

10.  Potential Role of Social Distancing in Mitigating Spread of Coronavirus Disease, South Korea.

Authors:  Sang Woo Park; Kaiyuan Sun; Cécile Viboud; Bryan T Grenfell; Jonathan Dushoff
Journal:  Emerg Infect Dis       Date:  2020-08-14       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.